NIPRO CORPORATION is pleased to announce that the head office has relocated as below mentioned, to the current address of Settsu City in Osaka Prefecture on October 1, 2023
- ■ Place of Relocation
New address: 3-26, Senriokashinmachi, Settsu, Osaka, 566-8510, Japan
(Nearest station: Kishibe Station on JR Tokaido Line (Kyoto Line)) - ■ Date of relocation
October 1, 2023
The location of the manufacturing and sales business in the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices has also changed as above mentioned.
- Fraudulent Email Warning（27KB）
News Release
- April 3, 2023
- Instruction for New Employees from President Sano (422KB)
- February 20, 2023
- Support for the Victims of the Turkey–Syria Earthquake (128KB)
- February 14, 2023
- Notice Regarding Unauthorized Access to NIPRO Subsidiary in China (79KB)
IR News
- November 29, 2023
- IR Materials
- September 28, 2023
- Annual Report
- August 29, 2023
- IR Materials
Our Business
Meeting the needs of front line medical treatment with unique products and technologies
To meet the needs of the front line of medical treatment, NIPRO creates unique products at its four research and development sites while leveraging the technologies cultivated in its various businesses.
Mission, Vision, Value
We will work as a truly global comprehensive medical manufacturer with a willingness to consider patient and user viewpoints.
